Organon & Co (OGN) saw an uptrend of 3212498% in the recent trading with $5700000.0 being its most recent. The current price level -56.93% lower than the highest price of $23.10 marked by the stock while trading over the past 52-weeks, whereas it is 24.22% higher than the lowest price of $8.01 the company dropped to over past 52-weeks. The latest news story on OGN appeared in (Zacks) under the title “Organon (OGN) Outpaces Stock Market Gains: What You Should Know” on Today.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Hold by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.
Organon & Co Earnings – What Happened With OGN
Coming around sales and income figures on OGN Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Organon & Co – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 259.96 million. OGN does have institutional investors; and they hold 80.32% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Organon & Co (NYSE:OGN) with an ownership of 32.58 million shares of the company or 12.6625 of the stake worth $674.39 million. The filing also reveals VANGUARD GROUP INC as the second largest holder in the company with a control over 11.7429 of the outstanding shares. Its stake is worth $625.41 million for having 30.21 million shares in hand.
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ also came holding a key position in the company during the recent quarter and it now holds 3.922 of the outstanding shares. With this there are now 901.0 institutions which have possession in OGN’s shares.
Key Metrics forOGN
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Organon & Co has a debt to equity ratio of 16.52.
Technical Analysis of Organon & Co (NYSE:OGN) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Organon & Co (OGN), we notice that the stock’s 20-day average volume is at 4,471,140 shares and 50% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 6,119,878 shares. And to end, OGN’s 100-day average volume is 4,965,970 shares with 100% of the long-term indicators pointing towards Sell for the stock.
